Megna Michael R's Form 4 filing
Kiniksa Pharmaceuticals International, plc (KNSA) · filed Sep 3, 2025
- Accession no.
- 0001415889-25-023564
- Filed
- Sep 3, 2025
- Trade date
- Sep 1-3, 2025
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Checked
This filing lists 8 non-derivative transactions and 7 derivative transactions. Open-market sales total $383.2K. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Megna Michael RCIK 0001464583 | Officer (CHIEF ACCOUNTING OFFICER) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Sep 1, 2025 | Class A Ordinary Share | MOption exerciseAcquired | +2,363 | – | – | 35,404 | Direct | |
| Sep 1, 2025 | Class A Ordinary Share | MOption exerciseAcquired | +2,557 | – | – | 37,961 | Direct | |
| Sep 1, 2025 | Class A Ordinary Share | MOption exerciseAcquired | +3,933 | – | – | 41,894 | Direct | |
| Sep 1, 2025 | Class A Ordinary Share | FTax withholdingDisposed | −4,282 | $33.49 | −$143,404.18 | 37,612 | Direct | |
| Sep 2, 2025 | Class A Ordinary Share | MOption exerciseAcquired | +774 | – | – | 38,386 | Direct | |
| Sep 2, 2025 | Class A Ordinary Share | FTax withholdingDisposed | −375 | $34.28 | −$12,855 | 38,011 | Direct | |
| Sep 3, 2025 | Class A Ordinary Share | MOption exerciseAcquired | +11,000 | $17.92 | +$197,120 | 49,011 | Direct | |
| Sep 3, 2025 | Class A Ordinary Share | SSaleDisposed | −11,000 | $34.84 | −$383,240 | 38,011 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Sep 1, 2025 | Class A Ordinary Share | AGrant or awardAcquired | +10,575 | $0.00 | $0 | 10,575 | Direct | |
| Sep 1, 2025 | Class A Ordinary Share | AGrant or awardAcquired | +21,150 | $0.00 | $0 | 21,150 | Direct | |
| Sep 1, 2025 | Class A Ordinary Share | MOption exerciseDisposed | −2,363 | $0.00 | $0 | 7,087 | Direct | |
| Sep 1, 2025 | Class A Ordinary Share | MOption exerciseDisposed | −2,557 | $0.00 | $0 | 5,115 | Direct | |
| Sep 1, 2025 | Class A Ordinary Share | MOption exerciseDisposed | −3,933 | $0.00 | $0 | 3,932 | Direct | |
| Sep 2, 2025 | Class A Ordinary Share | MOption exerciseDisposed | −774 | $0.00 | $0 | 0 | Direct | |
| Sep 3, 2025 | Class A Ordinary Share | MOption exerciseDisposed | −11,000 | $0.00 | $0 | 0 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.